ITGAE and ovarian carcinoma: In 2014, Webb et al. (32) and colleagues published a study in CLIN CANCER RES exploring the potential role of CD103-positive tumor-infiltrating lymphocytes (TILs) in immune surveillance in ovarian cancer.